<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               4 CONTRAINDICATIONS<BR>               <BR>                  EPZICOM Tablets are contraindicated in patients with:<BR>                  <BR>                     previously demonstrated hypersensitivity to abacavir or to any other component of the product. NEVER restart EPZICOM or any other abacavir-containing product following a hypersensitivity reaction to abacavir, regardless of HLA-B*5701 status [see Warnings and Precautions (5.1), Adverse Reactions (6)].<BR>                     <BR>                     hepatic impairment [see Use in Specific Populations (8.7)].<BR>                  <BR>               <BR>               <BR>               <BR>                  <BR>                     <BR>                        <BR>                           Previously demonstrated hypersensitivity to abacavir or any other component of the product. (4, 5.1)<BR>                           Hepatic impairment. (4)<BR>                        <BR>                     <BR>                  <BR>               <BR>            <BR>         </P></DIV></HTML>